EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A-K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, 'EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome', Annals of the Rheumatic Diseases, vol. 81, pp. 768-779. https://doi.org/10.1136/annrheumdis-2021-221733